RIFAMPICIN Side Effects

7020388-5 | Optic Neuritis
on Sep 22, 2010 Male patient from SOUTH AFRICA , 25 years of age, weighting 106.0 lb, was diagnosed with pulmonary tuberculosis, prophylaxis, routine health maintenance and was treated with Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: optic neuritis. Rifampicin dosage: . During the same period patient was treated with PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PYRIDOXINE HCL (View Pyridoxine Hcl Review and Pyridoxine Hcl Label ), VITAMIN B (View Vitamin B Review and Vitamin B Label ). Patient was hospitalized.

7012465-X | Cholestatic Liver Injury
Patient was taking Rifampicin (View Usage). Patient had the following side effects: cholestatic liver injury on Sep 20, 2010 from JAPAN Additional patient health information: Female patient , 48 years of age, was diagnosed with tuberculosis (What is tuberculosis?), crohn's disease (What is crohn's disease?) and. Rifampicin dosage: . During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), INFLIXIMAB (View Infliximab Review and Infliximab Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), MESALAZINE (View Mesalazine Review and Mesalazine Label ), POLYGAM S/D (View Polygam S/d Review and Polygam S/d Label ), CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ).

7012446-6 | Acute Hepatic Failure, Hepatic Enzyme Increased, Hepatitis Fulminant, Jaundice
Adverse event was reported on Sep 20, 2010 by a Male patient taking Rifampicin (View Usage) (Dosage: ) was diagnosed with latent tuberculosis and. Location: INDIA , 42 years of age, After Rifampicin was administered, patient had the following side effects: acute hepatic failure, hepatic enzyme increased, hepatitis fulminant, jaundice (What is jaundice?). During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ). Patient was hospitalized.

6992890-3 | Anaemia, Asthenia, Hyponatraemia, Ocular Icterus, Skin Lesion, Toxic Epidermal Necrolysis
on Sep 09, 2010 Male patient from COTE D'IVOIRE , 32 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, hyponatraemia, ocular icterus, skin lesion, toxic epidermal necrolysis. Rifampicin dosage: Unk. During the same period patient was treated with ISONIAZID (Unk) (View Isoniazid Review and Isoniazid Label ), PYRAZINAMIDE (Unk) (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL (NGX) (Unk) (View Ethambutol (ngx) Review and Ethambutol (ngx) Label ).


6987138-X | Optic Neuritis
on Sep 06, 2010 Male patient from SOUTH AFRICA , 25 years of age, weighting 106.0 lb, was diagnosed with pulmonary tuberculosis, prophylaxis and was treated with Rifampicin (View Usage). Patient had the following side effects: optic neuritis. Rifampicin dosage: . During the same period patient was treated with PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), MOXIFLOXACIN (View Moxifloxacin Review and Moxifloxacin Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PYRIDOXINE HCL (View Pyridoxine Hcl Review and Pyridoxine Hcl Label ), VITAMIN B (View Vitamin B Review and Vitamin B Label ). Patient was hospitalized.

6922550-6 | Hepatic Encephalopathy, Liver Disorder
Patient was taking Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: hepatic encephalopathy, liver disorder on Aug 03, 2010 from JAPAN Additional patient health information: Female patient , 53 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Rifampicin dosage: . During the same period patient was treated with SELENICA R (View Selenica-r Review and Selenica-r Label ), ISCOTIN (View Iscotin Review and Iscotin Label ), PYRAMIDE (View Pyramide Review and Pyramide Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), DEPAKENE (View Depakene Review and Depakene Label ), VALERIN (View Valerin Review and Valerin Label ). Patient was hospitalized.

6913553-6 | Cholestasis
Adverse event was reported on Aug 05, 2010 by a Female patient taking Rifampicin (View Usage) (Dosage: Dose Unit: 300 Mg) was diagnosed with disseminated tuberculosis and. Location: FRANCE , 37 years of age, Patient experienced the following unwanted or unexpected effects: cholestasis. During the same period patient was treated with MYAMBUTOL (Dose Unit: 400 Mg) (View Myambutol Review and Myambutol Label ), RIMIFON (Dose Unit: 150 Mg) (View Rimifon Review and Rimifon Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), RIFABUTIN (View Rifabutin Review and Rifabutin Label ), SUSTIVA (Dose:1 Unit(s)) (View Sustiva Review and Sustiva Label ), EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (Dose:1 Unit(s)) (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ). Patient was hospitalized.

6905419-2 | Hepatitis Fulminant
on Jul 23, 2010 Male patient from JAPAN , 76 years of age, was diagnosed with tuberculous pleurisy, diabetes mellitus, pyrexia, pain (What is pain?) and was treated with Rifampicin (View Usage). Patient had the following side effects: hepatitis fulminant. Rifampicin dosage: . During the same period patient was treated with ISCOTIN (View Iscotin Review and Iscotin Label ), PYRAMIDE (View Pyramide Review and Pyramide Label ), BASEN (View Basen Review and Basen Label ), ESANBUTOL (View Esanbutol Review and Esanbutol Label ), ZYLORIC ^FRESENIUS^ (View Zyloric ^fresenius^ Review and Zyloric ^fresenius^ Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6879816-8 | Mycobacterium Ulcerans Infection
on Jul 13, 2010 Male patient from AUSTRALIA , 66 years of age, was diagnosed with mycobacterium ulcerans infection and was treated with Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: mycobacterium ulcerans infection. Rifampicin dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ).

6870814-7 | Hepatitis Fulminant
Patient was taking Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis fulminant on Jul 14, 2010 from JAPAN Additional patient health information: Male patient , 76 years of age, was diagnosed with tuberculous pleurisy, diabetes mellitus, pyrexia, pain (What is pain?) and. Rifampicin dosage: . During the same period patient was treated with ISCOTIN (View Iscotin Review and Iscotin Label ), PYRAMIDE (View Pyramide Review and Pyramide Label ), BASEN (View Basen Review and Basen Label ), ESANBUTOL (View Esanbutol Review and Esanbutol Label ), ZYLORIC ^FRESENIUS^ (View Zyloric ^fresenius^ Review and Zyloric ^fresenius^ Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6822636-0 | Arthralgia, Arthropathy, Joint Swelling
Adverse event was reported on Jun 28, 2010 by a Male patient taking Rifampicin (View Usage) (Dosage: ) was diagnosed with pulmonary tuberculosis, prophylaxis and. Location: TANZANIA, UNITED REPUBLIC OF , 31 years of age, weighting 134.5 lb, Patient had the following side effects: arthralgia, arthropathy, joint swelling. During the same period patient was treated with PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), PYRIDOXINE HCL (View Pyridoxine Hcl Review and Pyridoxine Hcl Label ).

6815380-7 | Hyponatraemia
on Jun 23, 2010 Female patient from JAPAN , 94 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: hyponatraemia. Rifampicin dosage: 300 Mg/day. During the same period patient was treated with ISONIAZID (Unk) (View Isoniazid Review and Isoniazid Label ), EBUTOL (Unk) (View Ebutol Review and Ebutol Label ).

6766127-4 | Neutropenic Sepsis
on Jun 03, 2010 Female patient from UNITED KINGDOM , 22 years of age, weighting 59.92 lb, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenic sepsis. Rifampicin dosage: . During the same period patient was treated with ADCAL D3 (View Adcal-d3 Review and Adcal-d3 Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), MOXIFLOXACIN HYDROCHLORIDE (View Moxifloxacin Hydrochloride Review and Moxifloxacin Hydrochloride Label ), ONDASETRON (View Ondasetron Review and Ondasetron Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ).

6750004-9 | Neutropenic Sepsis
Patient was taking Rifampicin (View Usage). Patient had the following side effects: neutropenic sepsis on May 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 22 years of age, weighting 59.92 lb, was diagnosed with tuberculosis (What is tuberculosis?) and. Rifampicin dosage: 600 Mg. During the same period patient was treated with ADCAL D3 (View Adcal-d3 Review and Adcal-d3 Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), MOXIFLOXACIN HYDROCHLORIDE (View Moxifloxacin Hydrochloride Review and Moxifloxacin Hydrochloride Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ).

6747786-9 | Dermatitis, Dyspepsia, Obesity, Subcutaneous Abscess, White Blood Cell Count Decreased
Adverse event was reported on May 12, 2010 by a Female patient taking Rifampicin (View Usage) (Dosage: ) was diagnosed with schizophrenia, abdominal pain (What is abdominal pain?), depression (What is depression?), irritable bowel syndrome (What is irritable bowel syndrome?) and. Location: UNITED KINGDOM , 32 years of age, After Rifampicin was administered, patient had the following side effects: dermatitis, dyspepsia, obesity (What is obesity?), subcutaneous abscess, white blood cell count decreased. During the same period patient was treated with CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), CLOZARIL (View Clozaril Review and Clozaril Label ), DICYCLOVERINE (View Dicycloverine Review and Dicycloverine Label ), HIBISCRUB (View Hibiscrub Review and Hibiscrub Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), PEPPERMINT OIL (View Peppermint Oil Review and Peppermint Oil Label ).

6728089-5 | Hepatitis
on May 07, 2010 Female patient from UNITED KINGDOM , 84 years of age, weighting 110.2 lb, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). Rifampicin dosage: 600 Mg, Qd. During the same period patient was treated with ETHAMBUTOL (800 Mg, Qd) (View Ethambutol Review and Ethambutol Label ), ISONIAZID (300 Mg, Qd) (View Isoniazid Review and Isoniazid Label ), PYRAZINAMIDE (2 G, Qd) (View Pyrazinamide Review and Pyrazinamide Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

6725468-7 | Dermatitis, Subcutaneous Abscess, White Blood Cell Count Decreased
on May 05, 2010 Female patient from UNITED KINGDOM , 32 years of age, was diagnosed with schizophrenia, depression (What is depression?) and was treated with Rifampicin (View Usage). Patient had the following side effects: dermatitis, subcutaneous abscess, white blood cell count decreased. Rifampicin dosage: . During the same period patient was treated with CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), CLOZARIL (View Clozaril Review and Clozaril Label ).

6703878-1 | Liver Injury
Patient was taking Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: liver injury on Apr 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 84 years of age, weighting 110.2 lb, was diagnosed with tuberculosis (What is tuberculosis?) and. Rifampicin dosage: . During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), CLOPIDOGREL SULFATE (View Clopidogrel Sulfate Review and Clopidogrel Sulfate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ).

6631603-1 | Dyspnoea, Eosinophilia, Interstitial Lung Disease, Rash Pruritic
Adverse event was reported on Mar 09, 2010 by a Male patient taking Rifampicin (View Usage) (Dosage: ) was diagnosed with atypical mycobacterial infection and. Location: FRANCE , 57 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, eosinophilia, interstitial lung disease, rash pruritic. During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), DEXAMBUTOL (Dose Unit: 500 Mg) (View Dexambutol Review and Dexambutol Label ), PIRILENE (Dose Unit: 500 Mg) (View Pirilene Review and Pirilene Label ), ZECLAR (Dose Unit: 500 Mg) (View Zeclar Review and Zeclar Label ). Patient was hospitalized.

6623909-7 | Acute Hepatic Failure, Encephalopathy, Hepatotoxicity, Loss Of Consciousness
on Feb 22, 2010 Female patient from TUNISIA , 57 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin (View Usage). Patient had the following side effects: acute hepatic failure, encephalopathy, hepatotoxicity, loss of consciousness. Rifampicin dosage: . During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ). Patient was hospitalized.

6618583-X | Anaemia, Asthenia, Heart Sounds Abnormal, Hypoaesthesia, Renal Disorder
on Feb 19, 2010 Male patient from BRAZIL , 70 years of age, weighting 165.3 lb, was diagnosed with leprosy and was treated with Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: anaemia, asthenia, heart sounds abnormal, hypoaesthesia, renal disorder. Rifampicin dosage: . During the same period patient was treated with CLOFAZIMINE (NGX) (View Clofazimine (ngx) Review and Clofazimine (ngx) Label ), DAPSONE (View Dapsone Review and Dapsone Label ), AAS (1 Df/day) (View Aas Review and Aas Label ), VITAMIN A (1 Df, Bid) (View Vitamin A Review and Vitamin A Label ), VITAMIN B COMPLEX CAP (1 Df, Bid) (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ). Patient was hospitalized.

6591052-1 | Blood Amylase Increased, Lipase Increased, Pancreatitis
Patient was taking Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: blood amylase increased, lipase increased, pancreatitis on Feb 10, 2010 from FRANCE Additional patient health information: Female patient , 59 years of age, was diagnosed with endocarditis (What is endocarditis?), prophylaxis against gastrointestinal ulcer and. Rifampicin dosage: Dose Unit: 600 Mg. During the same period patient was treated with CALCIPARINE ^DIFREX^ (Dose Unit: 12500 Iu) (View Calciparine ^difrex^ Review and Calciparine ^difrex^ Label ), TARGOCID (Dose Unit: 400 Mg) (View Targocid Review and Targocid Label ), ESOMEPRAZOLE MAGNESIUM (Dose Unit: 40 Mg) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), CORDARONE (Dose Unit: 200 Mg) (View Cordarone Review and Cordarone Label ). Patient was hospitalized.

6547184-7 | Acute Respiratory Distress Syndrome, Endotracheal Intubation, Eosinophil Count Increased, Eosinophilic Pneumonia, Lower Respiratory Tract Inflammation, Mechanical Ventilation
Adverse event was reported on Jan 14, 2010 by a Female patient taking Rifampicin (View Usage) (Dosage: ) was diagnosed with arthritis infective and. Location: FRANCE , 68 years of age, Patient had the following side effects: acute respiratory distress syndrome, endotracheal intubation, eosinophil count increased, eosinophilic pneumonia, lower respiratory tract inflammation, mechanical ventilation. During the same period patient was treated with CUBICIN (Unk) (View Cubicin Review and Cubicin Label ). Patient was hospitalized.

6543175-0 | Weight Decreased
on Jan 15, 2010 Male patient from FRANCE , 80 years of age, weighting 85.98 lb, was diagnosed with infection (What is infection?), atrial fibrillation (What is atrial fibrillation?), thrombosis prophylaxis, agitation and was treated with Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: weight decreased. Rifampicin dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), LOVENOX (View Lovenox Review and Lovenox Label ), HALDOL (View Haldol Review and Haldol Label ), VITAMINE B (View Vitamine B Review and Vitamine B Label ). Patient was hospitalized.

6543164-6 | Weight Decreased
on Jan 15, 2010 Male patient from FRANCE , 80 years of age, weighting 85.98 lb, was diagnosed with infection (What is infection?), atrial fibrillation (What is atrial fibrillation?), thrombosis prophylaxis, agitation and was treated with Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: weight decreased. Rifampicin dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), LOVENOX (View Lovenox Review and Lovenox Label ), HALDOL (View Haldol Review and Haldol Label ), VITAMINE B (View Vitamine B Review and Vitamine B Label ). Patient was hospitalized.

6541672-5 | Ascites, Bladder Perforation, Bovine Tuberculosis, International Normalised Ratio Increased, Loss Of Consciousness, Melaena
Patient was taking Rifampicin (View Usage). Patient had the following side effects: ascites, bladder perforation, bovine tuberculosis, international normalised ratio increased, loss of consciousness, melaena on Jan 04, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 71 years of age, was diagnosed with tuberculosis (What is tuberculosis?), bovine tuberculosis and. Rifampicin dosage: . During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), IMMUCYST BCG (View Immucyst Bcg Review and Immucyst Bcg Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ). Patient was hospitalized.

6532152-1 | Ascites, Bladder Perforation, Blood Albumin Decreased, Blood Creatinine Increased, Bovine Tuberculosis, Haemoglobin Decreased, International Normalised Ratio Increased
Adverse event was reported on Dec 31, 2009 by a Male patient taking Rifampicin (View Usage) (Dosage: ) was diagnosed with tuberculosis (What is tuberculosis?), bladder cancer (What is bladder cancer?) and. Location: UNITED KINGDOM , 71 years of age, After Rifampicin was administered, patient had the following side effects: ascites, bladder perforation, blood albumin decreased, blood creatinine increased, bovine tuberculosis, haemoglobin decreased, international normalised ratio increased. During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), IMMUCYST (View Immucyst Review and Immucyst Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6532082-5 | Ascites, Bladder Perforation, Blood Albumin Decreased, Blood Creatinine Increased, Bovine Tuberculosis, Haemoglobin Decreased, International Normalised Ratio Increased
on Dec 31, 2009 Male patient from UNITED KINGDOM , 71 years of age, was diagnosed with tuberculosis (What is tuberculosis?), bladder cancer (What is bladder cancer?) and was treated with Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, bladder perforation, blood albumin decreased, blood creatinine increased, bovine tuberculosis, haemoglobin decreased, international normalised ratio increased. Rifampicin dosage: Unk. During the same period patient was treated with WARFARIN (NGX) (Unk) (View Warfarin (ngx) Review and Warfarin (ngx) Label ), ETHAMBUTOL HYDROCHLORIDE (Unk) (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), ISONIAZID (Unk) (View Isoniazid Review and Isoniazid Label ), TICE BCG (81 Mg, Unk) (View Tice Bcg Review and Tice Bcg Label ), WARFARIN SODIUM (Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6522454-7 | Acute Hepatic Failure, Cardiac Arrest, International Normalised Ratio Increased, Nausea, Nodule
on Dec 15, 2009 Female patient from UNITED STATES , 66 years of age, was treated with Rifampicin (View Usage). Patient had the following side effects: acute hepatic failure, cardiac arrest (What is cardiac arrest?), international normalised ratio increased, nausea (What is nausea?), nodule. Rifampicin dosage: . During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ). Patient was hospitalized.

6517514-0 | Acute Hepatic Failure, Hepatic Encephalopathy, Hepatocellular Injury
Patient was taking Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: acute hepatic failure, hepatic encephalopathy, hepatocellular injury on Dec 16, 2009 from SWITZERLAND Additional patient health information: Male patient , child 9 years of age, was diagnosed with disseminated tuberculosis, grand mal convulsion and. Rifampicin dosage: 300 Mg, (10 Mg/kg). During the same period patient was treated with ISONIAZID (300 Mg/day (10 Mg/kg)) (View Isoniazid Review and Isoniazid Label ), TIMONIL (700 Mg/day (300-0-400 Mg)) (View Timonil Review and Timonil Label ), PYRAZINAMIDE (750 Mg/day (25 Mg/kg)) (View Pyrazinamide Review and Pyrazinamide Label ).

6504967-7 | Coma, Convulsion, Hyponatraemia
Adverse event was reported on Dec 04, 2009 by a Female patient taking Rifampicin (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 79 years of age, Patient experienced the following unwanted or unexpected effects: coma, convulsion, hyponatraemia. During the same period patient was treated with ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CALCICHEW (View Calcichew Review and Calcichew Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ).

6500137-7 | Jarisch-herxheimer Reaction
on Dec 04, 2009 Female patient from SINGAPORE , 77 years of age, was treated with Rifampicin (View Usage). Patient had the following side effects: jarisch-herxheimer reaction. Rifampicin dosage: . During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ).

6493022-0 | Coma, Convulsion, Hyponatraemia
on Dec 04, 2009 Female patient from UNITED KINGDOM , 79 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and was treated with Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: coma, convulsion, hyponatraemia. Rifampicin dosage: 450 Mg, Bid. During the same period patient was treated with ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CALCICHEW (View Calcichew Review and Calcichew Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ).

6457322-2 | Hypoxia, Interstitial Lung Disease
Patient was taking Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: hypoxia, interstitial lung disease on Nov 19, 2009 from JAPAN Additional patient health information: Male patient , weighting 81.79 lb, was diagnosed with pulmonary tuberculosis, neuropathy peripheral, hypertension, constipation (What is constipation?) and. Rifampicin dosage: 450 Mg/day. During the same period patient was treated with ISCOTIN (300 Mg/day) (View Iscotin Review and Iscotin Label ), EBUTOL (750 Mg/day) (View Ebutol Review and Ebutol Label ), PYRAMIDE (1.2 G, Qd) (View Pyramide Review and Pyramide Label ), PYDOXAL (30 Mg, Qd) (View Pydoxal Review and Pydoxal Label ), NU LOTAN (25 Mg, Qd) (View Nu-lotan Review and Nu-lotan Label ), MILMAG (1050 Mg, Qd) (View Milmag Review and Milmag Label ), SENNOSIDE A+B (24 Mg, Qd) (View Sennoside A+b Review and Sennoside A+b Label ). Patient was hospitalized.

6428200-X | Gastrointestinal Haemorrhage, Gingival Bleeding, Haematuria, Melaena, Purpura, Thrombocytopenia
Adverse event was reported on Oct 22, 2009 by a Female patient taking Rifampicin (View Usage) (Dosage: 600 Mg, Bid, Oral) was diagnosed with pneumonia legionella, thrombosis prophylaxis and. Location: UNITED KINGDOM , 55 years of age, Patient had the following side effects: gastrointestinal haemorrhage, gingival bleeding, haematuria, melaena, purpura, thrombocytopenia. During the same period patient was treated with ENOXAPARIN (ENOXPARIN, HEPARIN FRACTION) (40 Mg, Subcutaneous) (View Enoxaparin (enoxparin, Heparin-fraction) Review and Enoxaparin (enoxparin, Heparin-fraction) Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

6375100-X | Stillbirth
on Sep 15, 2009 Female patient from SOUTH AFRICA , 22 years of age, weighting 92.59 lb, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: stillbirth. Rifampicin dosage: . During the same period patient was treated with PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), VIT B COMPLEX (Dose: 2 Tbl) (View Vit B Complex Review and Vit B Complex Label ). Patient was hospitalized.

6366987-5 | Abdominal Pain, Adrenal Insufficiency, Arthralgia, Pyrexia, Renal Impairment, Shock
on Sep 04, 2009 Male patient from JAPAN , 69 years of age, was diagnosed with pulmonary tuberculosis, interstitial lung disease, rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), adrenal insufficiency, arthralgia, pyrexia, renal impairment, shock. Rifampicin dosage: 450 Mg, Oral. During the same period patient was treated with ESANBUTOL (NGX) (ETHAMBUTOL) TABLET (750 Mg, Oral) (View Esanbutol (ngx) (ethambutol) Tablet Review and Esanbutol (ngx) (ethambutol) Tablet Label ), ISONIAZID (300 Mg, Oral) (View Isoniazid Review and Isoniazid Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NEORAL (View Neoral Review and Neoral Label ). Patient was hospitalized.

6340317-7 | Hypokalaemia
Patient was taking Rifampicin (View Usage). Patient had the following side effects: hypokalaemia on Aug 24, 2009 from JAPAN Additional patient health information: Female patient , 66 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?), cardiac failure and. Rifampicin dosage: 450 Mg, Oral. During the same period patient was treated with LASIX (80 Mg, Oral) (View Lasix Review and Lasix Label ), ALDACTONE (25 Mg, Oral) (View Aldactone Review and Aldactone Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6335787-4 | Abdominal Pain, Adrenal Insufficiency, Arthralgia, Hyperkalaemia, Hyponatraemia, Pyrexia, Renal Impairment
Adverse event was reported on Aug 17, 2009 by a Male patient taking Rifampicin (View Usage) (Dosage: 450 Mg, Oral) was diagnosed with pulmonary tuberculosis, interstitial lung disease, rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 69 years of age, After Rifampicin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), adrenal insufficiency, arthralgia, hyperkalaemia, hyponatraemia, pyrexia, renal impairment. During the same period patient was treated with ESANBUTOL (NGX) (ETHAMBUTOL) TABLET (750 Mg, Oral) (View Esanbutol (ngx) (ethambutol) Tablet Review and Esanbutol (ngx) (ethambutol) Tablet Label ), ISONIAZID (300 Mg, Oral) (View Isoniazid Review and Isoniazid Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6315133-2 | Pneumonectomy, Tuberculosis
on Aug 05, 2009 Female patient from INDIA , 24 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonectomy, tuberculosis (What is tuberculosis?). Rifampicin dosage: Daily. During the same period patient was treated with ISONIAZID (Daily) (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL HYDROCHLORIDE (Daily) (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), CO AMOXICLAV (NGX) (AMOXICILLIN, CLAVULANATE) (View Co-amoxiclav (ngx) (amoxicillin, Clavulanate) Review and Co-amoxiclav (ngx) (amoxicillin, Clavulanate) Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), PYRAZINAMIDE (Daily) (View Pyrazinamide Review and Pyrazinamide Label ), CYCLOSERINE (View Cycloserine Review and Cycloserine Label ), ETHIONAMIDE (ETHIONAMIDE) (View Ethionamide (ethionamide) Review and Ethionamide (ethionamide) Label ).

6313625-3 | Hypokalaemia
on Aug 06, 2009 Female patient from JAPAN , 66 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifampicin (View Usage). Patient had the following side effects: hypokalaemia. Rifampicin dosage: 450 Mg, Oral. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ).

6310762-4 | Optic Neuritis
Patient was taking Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: optic neuritis on Jul 31, 2009 from DENMARK Additional patient health information: Female patient , 77 years of age, was diagnosed with mycobacterium avium complex infection and. Rifampicin dosage: 600 Mg, Qd, Oral. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ).

6307541-0 | Adrenal Insufficiency
Adverse event was reported on Jul 24, 2009 by a Male patient taking Rifampicin (View Usage) (Dosage: Oral) was diagnosed with pulmonary tuberculosis and. Location: JAPAN , 69 years of age, Patient experienced the following unwanted or unexpected effects: adrenal insufficiency. During the same period patient was treated with ESANBUTOL (NGX) (ETHAMBUTOL) TABLET (Oral) (View Esanbutol (ngx) (ethambutol) Tablet Review and Esanbutol (ngx) (ethambutol) Tablet Label ), ISONIAZID (Oral) (View Isoniazid Review and Isoniazid Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

6295168-9 | Diabetes Mellitus, Hepatic Enzyme Increased
on Jul 20, 2009 Female patient from SOUTH AFRICA , 54 years of age, weighting 82.67 lb, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifampicin (View Usage). Patient had the following side effects: diabetes mellitus, hepatic enzyme increased. Rifampicin dosage: . During the same period patient was treated with PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), RIDAQ (Dose: 12.5/25) (View Ridaq Review and Ridaq Label ), NORVASC (Dose: 5-10) (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6251252-7 | Confusional State, Delirium, Psychomotor Hyperactivity
on Jun 17, 2009 Female patient from SWITZERLAND , 67 years of age, was diagnosed with bone tuberculosis, depression (What is depression?), back pain (What is back pain?) and was treated with Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: confusional state, delirium, psychomotor hyperactivity. Rifampicin dosage: 600 Mg Qw3 Oral. During the same period patient was treated with RIMIFON (900 Mg Qw3 Oral) (View Rimifon Review and Rimifon Label ), REMERON (30 Mg Qd Oral) (View Remeron Review and Remeron Label ), ETHAMBUTOL (ETHAMBUTOL) TABLET, 400 MG (1200mg, Qw3, Oral) (View Ethambutol (ethambutol) Tablet, 400 Mg Review and Ethambutol (ethambutol) Tablet, 400 Mg Label ), NEURONTIN (300 Per E Weeks Oral) (View Neurontin Review and Neurontin Label ), PYRAZINAMIDE (1200 Mg Qw3 Oral) (View Pyrazinamide Review and Pyrazinamide Label ). Patient was hospitalized.

6244546-2 | Asterixis, Depressed Level Of Consciousness, Disseminated Intravascular Coagulation, Encephalopathy, Facial Spasm, Haemorrhage, Hepatitis Fulminant, Hypoglycaemia
Patient was taking Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: asterixis, depressed level of consciousness, disseminated intravascular coagulation, encephalopathy, facial spasm, haemorrhage, hepatitis fulminant, hypoglycaemia on Jun 12, 2009 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with pulmonary tuberculosis and. Rifampicin dosage: 450 Mg, Qd, Oral. During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), ADONA (CARBAZOCHROME SODIUM SULFONATE) TABLET (View Adona (carbazochrome Sodium Sulfonate) Tablet Review and Adona (carbazochrome Sodium Sulfonate) Tablet Label ), TRANSAMIN (TRANEXAMIC ACID) (View Transamin (tranexamic Acid) Review and Transamin (tranexamic Acid) Label ), SIGMART (NICORANDIL) TABLET (View Sigmart (nicorandil) Tablet Review and Sigmart (nicorandil) Tablet Label ), BROTIZOLAM (BROTIZOLAM) TABLET (View Brotizolam (brotizolam) Tablet Review and Brotizolam (brotizolam) Tablet Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ).

6218223-8 | Guillain-barre Syndrome, Pneumonia Aspiration
Adverse event was reported on Jun 02, 2009 by a Male patient taking Rifampicin (View Usage) (Dosage: ) was diagnosed with tuberculosis (What is tuberculosis?) and. Location: ZAMBIA , 35 years of age, weighting 120.4 lb, Patient had the following side effects: guillain-barre syndrome (What is guillain-barre syndrome?), pneumonia aspiration. During the same period patient was treated with PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ). Patient was hospitalized.

6208772-0 | Acute Hepatic Failure
on May 18, 2009 Female patient from UNITED STATES , 66 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifampicin (View Usage). After Rifampicin was administered, patient had the following side effects: acute hepatic failure. Rifampicin dosage: . During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL HCL (View Ethambutol Hcl Review and Ethambutol Hcl Label ). Patient was hospitalized.

6199990-9 | Pain
on May 11, 2009 Male patient from , 65 years of age, weighting 143.3 lb, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifampicin (View Usage). Patient experienced the following unwanted or unexpected effects: pain (What is pain?). Rifampicin dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), ETHAMBUTOL HCL (View Ethambutol Hcl Review and Ethambutol Hcl Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), SERETIDE (View Seretide Review and Seretide Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

6191395-X | Acute Hepatic Failure, Cardiac Arrest, International Normalised Ratio Increased
Patient was taking Rifampicin (View Usage). Patient had the following side effects: acute hepatic failure, cardiac arrest (What is cardiac arrest?), international normalised ratio increased on May 11, 2009 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and. Rifampicin dosage: . During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), ETHAMBUTOL HCL (View Ethambutol Hcl Review and Ethambutol Hcl Label ). Patient was hospitalized.